Australia, New Zealand (ANZ), 20 March 2026. Opella has received $1.94 million in funding from the Australian Renewable Energy Agency (ARENA) to deliver an Australian manufacturing first: a major site decarbonization project at its facility in North Brisbane. By leveraging an innovative heat pump electrification approach to dehumidification, the project aims to revolutionize energy use and carbon reduction practices in manufacturing.
This comprehensive solution is projected to achieve an annual reduction of ~1200 tonnes of CO₂, with only a modest ~2% increase in electrical consumption, demonstrating exceptional efficiency in carbon reduction. As a purpose-driven healthcare company, this concrete emissions elimination project in the ANZ market positions Opella to further its global leadership in sustainability. This marks a significant milestone that helps the B Corp certified company achieve its net-zero goals.
Lee Coomber, General Manager Opella ANZ.
The ARENA funding is strong recognition and support for the Opella Dehumidification and Heat Pump Electrification Project. Here Opella is able to showcase how traditional energy-intensive processes can be reimagined and electrified, bringing us one step closer to a decarbonized manufacturing sector.
The Opella ANZ site already operates on 100% renewable electricity, including 2,700 solar panels, providing around 22% of the site's total electricity. This electrification project is the next frontier in sustainability, eliminating gas as a fuel source and setting a new benchmark for sustainable manufacturing.
Stuart Addinall, Head of Manufacturing and Supply at Opella ANZ.
In line with Opella's broader sustainability goals and decarbonization strategies, we aim to lead the change in Brisbane with a completely new approach. This means ensuring the products our customers trust are made sustainably for generations to come. This electrification project we officially launch today is the result of two years of hard work and dedication of our passionate teams.
Opella ANZ employs over 300 people across science, engineering, research & development, quality control, manufacturing, supply and marketing. Opella’s local manufacturing and supply workforce in Brisbane makes up 60% of its total workforce.
Opella ANZ's trusted brands, Nature's Own, Ostelin and Cenovis, have deep roots in Brisbane, where vitamins and minerals have been manufactured for generations. Today, the site produces over 2.1 billion tablets and soft-gel capsules annually.
About Opella.
Opella is the self-care challenger with the purest and third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people’s hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers, including one in Virginia, Australia.
Headquartered in France, Opella is the proud maker of many of ANZ most loved brands, including Telfast, Buscopan, Ostelin, Phenergen, Nature’s Own and Cenovis. B Corp certified globally, we are active players in the journey towards healthier people and planet.
Find out more about our mission at www.opella.com.
Press Contact.
Sara Ross | Head of Corporate Affairs Opella ANZ | sara.ross@sanofi.com. +61 0475 727 637.
In your pocket.
pdf version.
